Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis
Links shared publicly online about this topic.
- 1,242total visits
Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis
Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced today that Copaxone® (glatiramer acetate injection), has now achieved one million patient years of experience in the treatment of
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Pharma, Copaxone, Teva Pharmaceutical Industries
Most Recently Shared on April 14, 2010 at 4:07 am By:
Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis Teva .. http://dld.bz/ajej
Advertisement
